Disclosure requirements of competitor names/schedules
-
Hi PAAB—could you kindly clarify if the below section of the code applies solely to the manufacturer's product or all products mentioned within an APS? Does this vary if the manufacturer opts to include the brand name of another manufacturer's product within an APS, not just its generic name (assume this is permissible due to an acceptable head-to-head trial)?
2.2 In all APS for pharmaceutical products, the brand or trade name, the non-proprietary or generic name and the Federal drug schedule of the product must appear in juxtaposition at least once within advertising copy and must be in good contrast and be legible. -
Hi PAAB—could you kindly clarify if the below section of the code applies solely to the manufacturer's product or all products mentioned within an APS? Does this vary if the manufacturer opts to include the brand name of another manufacturer's product within an APS, not just its generic name (assume this is permissible due to an acceptable head-to-head trial)?
2.2 In all APS for pharmaceutical products, the brand or trade name, the non-proprietary or generic name and the Federal drug schedule of the product must appear in juxtaposition at least once within advertising copy and must be in good contrast and be legible.Hello @palanski
PAAB Code s2.2 pertains only to the promoted product(s). There are separate code sections that relate to other products (e.g., acknowledgement of trademarks where relevant). The sponsor’s legal department can help you ensure that you are meeting legal disclosure requirements for those other products.
